Serial tests of T-cell function predict long-term survival in an elderly cohort from a Scottish general practice
J. C. Murdoch 1 3 , M. Elwood 2 , Phyu Sin Aye 21 Department of General Practice and Rural Medicine, Dunedin School of Medicine, University of Otago, New Zealand
2 University of Auckland, Auckland, New Zealand
3 Corresponding author. Email: camgp@xtra.co.nz
Journal of Primary Health Care 12(1) 21-28 https://doi.org/10.1071/HC19079
Published: 30 March 2020
Journal Compilation © Royal New Zealand College of General Practitioners 2020 This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
Abstract
INTRODUCTION: The care of the elderly presents serious challenges to general practice. In 1979, the first author took over the care of a general practice in Scotland where 21% of registered patients were elderly. This resulted in a high workload and prompted research into how this might be mitigated.
AIM: To measure serial tests of T-cell function in these individuals in order to identify those whose immune response was impaired and assess the effect of this in a long term follow up.
METHODS: This research comprised two phases. In the assessment phase (1979–82), patients were invited to have a 3-monthly visit from a research nurse where clinical measurements were made and blood taken for immunological tests of lymphocyte proliferation after culture with phytohaemagglutinin (PHA). For each patient, all records were surveyed and problems identified. In the follow-up phase (post 1982), all deaths were assessed with complete life-long follow up.
RESULTS: Of 405 people originally invited to participate in this research, 314 (78%) agreed and 246 (153 female, 93 male) entered the follow-up phase and were followed for 36.5 years. Factors significantly associated with lower survival were age, male sex, diastolic blood pressure, current smoking and poor immune function, as demonstrated by the percentage of negative responses in at least six PHA tests. Considered in four groups by percentage of failing tests, the lowest group had a life span 4 years shorter than the highest (P < 0.01). The four groups did not differ significantly in general practitioner workload, diagnosed problems or causes of death.
DISCUSSION: Poor cellular immune function was associated with poor survival over lifetime follow up of >30 years. A sensitive, specific and longitudinally consistent measure of T-cell function is required to predict who may be at risk of poorer survival within our practices.
KEYwords: General practice; ageing; cohort study; immunology; primary health care; aged; longitudinal studies; death certificates; immune function phenomena.
References
[1] Stahl EC, Brown BN. Cell therapy strategies to combat immunosenescence. Organogenesis. 2015; 11 159–72.| Cell therapy strategies to combat immunosenescence.Crossref | GoogleScholarGoogle Scholar | 26588595PubMed |
[2] Pawelec G. Does the human immune system ever really become “senescent?” F1000Res. 2017; 6 1323
| Does the human immune system ever really become “senescent?”Crossref | GoogleScholarGoogle Scholar |
[3] Murdoch JC. Characteristics of the elderly in an urban general practice. PhD Thesis. University of Dundee; 1983.
[4] Gibbs JH, Brown RA, Robertson AJ, et al. A new method of testing for mitogen-induced lymphocyte stimulation: measurement of the percentage of growing cells and of some aspects of their cell kinetics with an electronic particle counter. J Immunol Methods. 1979; 25 147–58.
| A new method of testing for mitogen-induced lymphocyte stimulation: measurement of the percentage of growing cells and of some aspects of their cell kinetics with an electronic particle counter.Crossref | GoogleScholarGoogle Scholar | 422855PubMed |
[5] Brown RA, McWalter R, Slidders W, Gibbs J. Beck Measurement by Quantimet 720 of the proportion of actively growing cells in tissue cultures of human lymphocytes. J Microsc. 1979; 115 51–63.
| Beck Measurement by Quantimet 720 of the proportion of actively growing cells in tissue cultures of human lymphocytes.Crossref | GoogleScholarGoogle Scholar | 370399PubMed |
[6] Dionigi R, Zonta A, Albertario F, et al. Cyclic variation in the response of lymphocytes to phytohemagglutinin in healthy individuals. Transplantation. 1973; 16 550–7.
| Cyclic variation in the response of lymphocytes to phytohemagglutinin in healthy individuals.Crossref | GoogleScholarGoogle Scholar | 4755096PubMed |
[7] Roberts-Thomson IC, Whittingham S, Youngchaiyud U, Mackay IR. Ageing, immune response and mortality. Lancet. 1974; 304 368–70.
| Ageing, immune response and mortality.Crossref | GoogleScholarGoogle Scholar |
[8] Murasko DM, Weiner P, Kaye D. Association of lack of mitogen-induced lymphocyte proliferation with increased mortality in the elderly. Aging: Immunol Infect Dis. 1988; 1 1–6.
[9] Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol. 1990; 45 M45–8.
| Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60.Crossref | GoogleScholarGoogle Scholar | 2313042PubMed |
[10] Ferguson FG, Wikby A, Maxson P, et al. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci. 1995; 50A B378–82.
| Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors.Crossref | GoogleScholarGoogle Scholar |
[11] Wikby A, Maxson P, Olsson J, et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev. 1998; 102 187–98.
| Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study.Crossref | GoogleScholarGoogle Scholar | 9720651PubMed |
[12] Olsson J, Wikby A, Johansson B, et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev. 2000; 121 187–201.
| 11164473PubMed |
[13] Pawelec G. Immune signatures associated with mortality differ in elderly populations from different birth cohorts and countries even within northern Europe. Mech Ageing Dev. 2019; 177 182–5.
| Immune signatures associated with mortality differ in elderly populations from different birth cohorts and countries even within northern Europe.Crossref | GoogleScholarGoogle Scholar | 29654793PubMed |
[14] Cawthon RM, Smith KR, O’Brien E, et al. Association between telomere length in blood and mortality in people aged 60 years or greater. Lancet. 2003; 361 393–95.
| Association between telomere length in blood and mortality in people aged 60 years or greater.Crossref | GoogleScholarGoogle Scholar | 12573379PubMed |
[15] Mather KA, Jorm AF, Parslow RA, Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci. 2011; 66A 202–13.
| Is telomere length a biomarker of aging? A review.Crossref | GoogleScholarGoogle Scholar |
[16] Barron E, Lara J, White M, Mathers JC. Blood borne biomarkers of mortality risk: systematic review of cohort studies. PLOS ONE. 2015; 10 e0127550
| Blood borne biomarkers of mortality risk: systematic review of cohort studies.Crossref | GoogleScholarGoogle Scholar | 26372210PubMed |
[17] Belsky DW, Caspi A, Houts R, et al. Quantification of biological aging in young adults. Proc Natl Acad Sci USA. 2015; 112 E4104–10.
| Quantification of biological aging in young adults.Crossref | GoogleScholarGoogle Scholar | 26150497PubMed |
[18] Frasca D, Diaz A, Romero M, Blomberg BB. Ageing and obesity similarly impair antibody responses. Clin Exp Immunol. 187 64–70.
| Ageing and obesity similarly impair antibody responses.Crossref | GoogleScholarGoogle Scholar |
[19] Pereira Gray DJ, Holdaway-Lee K, White E, et al. Continuity of care with doctors-a matter of life and death? A systematic review of continuity of care and mortality. BMJ Open. 2018; 8 e021161
| Continuity of care with doctors-a matter of life and death? A systematic review of continuity of care and mortality.Crossref | GoogleScholarGoogle Scholar | 29959146PubMed |
[20] Müller L, Pawelec G. As we age: does slippage of quality control in the immune system lead to collateral damage? Ageing Res Rev. 2015; 23 116–23.
| As we age: does slippage of quality control in the immune system lead to collateral damage?Crossref | GoogleScholarGoogle Scholar | 25676139PubMed |
[21] Mackenzie J. in The Future of Medicine. London: Oxford Medical Publications; 1919.
